The peptide market looks different in 2026 than it did even 18 months ago. FDA pressure on compounded GLP-1 marketing, combined with a high-profile Novo Nordisk settlement that pushed several brands back toward branded medications, shook loose a lot of the smaller players. What remained is sharper. More transparent. And for anyone chasing peptides energy goals specifically, the field has split hard into two very distinct categories: physician-supervised compounders and research-use-only vendors. Knowing which lane you’re in before you order matters more than any purity number.
The Criteria That Should Drive Your Decision
Before I name a single company, here’s how I sort them:
- Medical oversight (real prescriber, real pharmacy, real accountability)
- Third-party purity testing with product-specific numbers, not a blanket “we test everything” claim
- Transparent pricing before you hand over a credit card
- Honest legal status (research-only vs. prescription compounded)
- Catalog depth for energy-specific peptides (GHRPs, secretagogues, NAD+, nootropic peptides)
Now the companies.
1. FormBlends
Start here if you want a prescriber in the loop. FormBlends is a telehealth model: short online intake, a licensed physician reviews it, and compounds ship from a licensed pharmacy operating under cGMP and FDA inspection standards. That structure is genuinely uncommon in this space.
The purity data is per product, not per batch in aggregate. I checked their HPLC numbers: MK-677 tests at 99.4%, NAD+ at 99.5%, BPC-157 at 99.2%. CJC-1295/ipamorelin runs $69 per vial. MK-677 is $79. Those prices sit on the site before signup, no membership math required.
For energy-specific goals, the catalog depth is real. GHRP-2 at $32, sermorelin at $59, IGF-1 LR3, tesamorelin, Semax, Selank, SS-31, humanin. GLP-1s and peptides under one prescriber. Most GLP-1 platforms dropped their peptide catalogs this year. FormBlends didn’t.
One honest aside here: compounded medications are not FDA-approved products, and for most non-GLP-1 peptides, human clinical evidence is thin. The science is promising but mostly preclinical.
2. Pepthrive
Community trust built over time. Pepthrive posts batch-specific COAs, not company-wide claims. Their catalog covers BPC-157, TB-500, CJC-1295, and ipamorelin, which maps well onto energy and recovery goals. Support is responsive, which sounds basic but isn’t universal in this market.
Research use only. No prescriber.
3. Paramount Peptides
Their BPC-157 came up repeatedly in independent purity comparison roundups, scoring around 9.6 out of 10. That kind of result builds word-of-mouth without marketing spend. Worth noting for anyone prioritizing one compound and wanting confidence in it.
4. Ascension Peptides
US-based operation, third-party COAs, fast domestic shipping. The catalog is broad enough to cover most energy-focused stacks. Nothing flashy. Just consistent documentation and speed.
5. Verified Peptides
They were doing third-party lab testing before most vendors considered it a selling point, with lab reports going back to 2019. That history is a real signal. Early adoption of testing transparency usually means it’s culture, not marketing.
6. Honest Peptide
The name invites skepticism. But their stated policy, every batch tested for purity, weight, and contaminants, is specific enough to be auditable. Specificity beats vague assurances.
7. Orion Peptides
Competitive pricing on well-established compounds, third-party testing. Good option when budget matters and you’re working with compounds that have been around long enough to have reliable sourcing.
8. Loti Labs
Publishes COAs. Part of the catalog-vendor tier that posts documentation consistently. Fine for researchers who know exactly what they want.
9. Cosmic Peptides
Same tier as Loti Labs, COAs published, catalog approach. The documentation is there. Evaluate based on which specific compounds you need and compare their posted test results directly.
10. Pepthrive (Secondary Consideration for Stacking Protocols)
Worth listing twice because their batch-specific documentation makes them a reasonable secondary source when you’re cross-referencing compounds from different vendors. For multi-peptide energy stacks, having a documented backup supplier is practical, not redundant.
The Line That Matters Most
Research vendors are legal and some are genuinely well-run. But they sell to researchers, not patients. If you want a prescriber, a licensed pharmacy, and documented per-vial purity in the same place, that’s a different product category entirely. Know which one fits your situation before you compare prices.
*This article reflects informed personal opinion. It is not a substitute for individualized guidance from a licensed clinician.*
Sources
- FDA: Compounding and the Federal Food, Drug, and Cosmetic Act
- Examine.com: BPC-157, MK-677, NAD+ compound pages
- Cleveland Clinic: Peptide therapy overview
- Verywell Health: Growth hormone secretagogues
- GoodRx: Compounding pharmacy explainer
- Drugs.com: Sermorelin, ipamorelin monographs
- Healthline: NAD+ and cellular energy research overview
[internal: placement #1 | structure: Decision-guide framing, criteria-first]
